PET/CT超声融合用于经皮活检:一项回顾性单中心研究及文献复习
该回顾性单中心研究评估了18F-FDG PET/CT超声融合对FDG高摄取病灶经皮活检的诊断率与并发症率,纳入2014年10月至2020年7月间36例已知或疑似恶性肿瘤患者,全部获得可分析组织,其中14例(38.9%)为恶性、22例(61.1%)为非肿瘤组织,未记录术中或术后并发症。
要点
- 36例患者均获得可分析组织,诊断取材成功。
- 组织学评估显示14例(38.9%)为恶性,22例(61.1%)为非肿瘤组织。
- 未记录术中或术后并发症。
核心结论
- PET/CT与超声融合用于FDG高摄取病灶经皮活检可获得极好诊断率且并发症风险低。
研究设计与样本
- 回顾性单中心研究,纳入2014年10月至2020年7月间36例(男15例、女21例)已知或疑似恶性肿瘤且有既往PET/CT影像的患者,使用实时PET/CT超声融合行经皮活检。
- 另经Medline检索并评估相关文献,检索词包括「融合影像」「PET/CT融合」「PET/CT引导活检」「PET/US融合」「超声融合」「超声融合引导活检」。
主要发现
- 全部36例均获得足以分析的组织。
- 组织学评估显示14例(38.9%)为恶性,22例(61.1%)为非肿瘤组织。
- 未记录术中或术后并发症。
- 配准使用General Electric LOGIQ E9软件实现。
临床怎么用
- 作者认为,PET/CT与超声融合用于FDG高摄取病灶经皮活检可获得极好诊断率且并发症风险低。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The aim of this study was to assess the diagnostic yield and complication rate of 18 F-FDG PET/CT ultrasound (US) fusion for percutaneous biopsy of FDG-avid lesions among patients with known or suspected malignancy. PATIENTS AND METHODS: We describe the clinical, imaging, and histopathologic features of 36 patients who underwent percutaneous biopsy using real-time PET/CT US fusion. In addition, we review the literature on PET/CT US fusion. Using Medline, the following MeSH terms were searched and relevant citations assessed: "fusion imaging," "PET/CT fusion," "PET/CT-guided biopsy," "PET/US fusion," "ultrasound fusion," and "ultrasound fusion-guided biopsy." RESULTS: A total of 36 patients (15 men, 21 women) with known or suspected malignancy and prior PET/CT imaging underwent percutaneous biopsy of FDG-avid lesions using PET/CT US fusion between October 2014 and July 2020. Coregistration was achieved using General Electric LOGIQ E9 software. Adequate tissue for analysis was obtained in all 36 patients. Histologic evaluation revealed malignancy in 14 patients (38.9%) and nonneoplastic tissue in 22 patients (61.1%). No intraprocedural or postprocedural complications were recorded. CONCLUSIONS: Fusion of PET/CT and US for percutaneous biopsy of FDG-avid lesions can be used to achieve excellent diagnostic yield with a low risk of complications.
引用
- Beutler BD, Whang G, Tchelepi H, et al. PET/CT Ultrasound Fusion for Percutaneous Biopsy: A Retrospective Single-Center Study and Review of the Literature. Clin Nucl Med. 2022. PMID: 35452012. doi:10.1097/RLU.0000000000004220
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。